New international study to test exercise in heart failure patients

Key points
- Cardiologists at Wake Forest University Baptist Medical Center are helping to lead a large international study involving 83 other sites that will test 3,000 patients in an effort to determine whether exercise really is good for heart failure patients.
- Though doctors have promoted the value of exercise for a variety of disorders for years, "exercise training has not been definitively established as safe in the group of patients who primarily have heart failure," said Dalane W.
- "Controlled clinical trials have shown that exercise training improves physiological measurements" such as the distance that patients can walk in six minutes, they said after analyzing 14 trials.
- The new trial, called Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) "is the largest randomized clinical trial of exercise training ever performed," Kitzman said.
Cardiologists at Wake Forest University Baptist Medical Center are helping to lead a large international study involving 83 other sites that will test 3,000 patients in an effort to determine whether exercise really is good for heart failure patients.
Though doctors have promoted the value of exercise for a variety of disorders for years, "exercise training has not been definitively established as safe in the group of patients who primarily have heart failure," said Dalane W. Kitzman M.D., a cardiologist who is principal investigator at Wake Forest Baptist, and colleagues, writing in the American Heart Journal.
"Controlled clinical trials have shown that exercise training improves physiological measurements" such as the distance that patients can walk in six minutes, they said after analyzing 14 trials. "None of these trials enrolled a sufficient number of patients to properly evaluate the impact of exercise training on death and hospitalization."
The new trial, called Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) "is the largest randomized clinical trial of exercise training ever performed," Kitzman said. "The trial represents a critical step in establishing exercise as a therapy for patients with left ventricular dysfunction" (reduced heart contractions).
He added, "The patient population enrolled in this trial will be a broad representation of heart failure patients, including large numbers of women, minorities and people from low socio-economic status."
"The HF-ACTION trial has been designed so that if the intervention is beneficial, the treatment can be translated rapidly into general practice," Kitzman said. In fact, the study leaders have met with Centers for Medicare & Medicaid Services, the office that assesses whether there is enough proof that a treatment is effective and safe in order to be paid for by Medicare, to help ensure that exercise programs would qualify for Medicare if the study is positive.
There are 84 clinical study sites in the trial across North America and Europe. At the Wake Forest Baptist site, 120 participants have been enrolled so far, the second-highest number across all sites.
The patients in the study will receive either exercise training or "usual care." Those in the exercise arm will receive 36 supervised exercise training sessions at a facility, using either bikes or walking. After the first 18 sessions, the patients will start home-based exercise, and will exercise exclusively at home after the second 18 sessions. They'll come back for facility-based training every three months.
The supervised training protocol is based on the traditional cardiac rehabilitation program of 36 sessions currently covered by insurers for patients after heart bypass surgery.
All patients in HF-ACTION will receive a self-management education program on topics such as medicines and their side effects, managing fluids, the importance of adhering to a low sodium diet.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsNovel device successfully treats central sleep apnea in heart failure
A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients, according to research presented today at the Heart Failure Congress 2014, held 17-20 May…
20 May 2014
NewsPrevent premature deaths from heart failure, urges the Heart Failure Association
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) is calling for global policy change relating to heart failure. An international white paper, Heart failure: preventing disease and death…
15 May 2014
NewsEarly menopause ups heart failure risk, especially for smokers
Women who go through menopause early - at ages 40 to 45 - have a higher rate of heart failure, according to a new study published online today in Menopause, the journal of The North American Menopause Society (NAMS).…


